Syngene Acquires its First Manufacturing Facility in the US
Syngene Acquires its First Manufacturing Facility in the US
Biologics Drug Substance Facility in Baltimore Expected to Enhance Global Innovator Flexibility
...
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.